SlideShare a Scribd company logo
1 of 40
Download to read offline
Antecedents
Group no. 01
Group Members:
Rana Ahmed (PHA-14001)
Mahfujul Hasan (PHA-14002)
Shahida Yeasmin Sima (PHA-14005)
Shamima Akter Sumi (PHA-14007)
14 April 2019 1
Contents
Introduction to Pathology
Definition
Father of Modern Pathology
Scope
Core aspects
Cellular Injury and Adaptation
Stages of the cellular response
Adaptation
Hypertrophy
Hyperplasia
Atrophy
Metaplasia
Cell injury
Intracellular Accumulations
14 April 2019 2
What Is Pathology
• Pathology is the study (logos) of diseases (pathos).
• The study of the structural, biochemical and functional changes in
cells, tissues and organs that underlie diseases.
• It attempts to explain sign and symptoms by use of
Molecular
Microbiologic
Immunologic
Morphologic techniques
14 April 2019 3
Rudolf Virchow
Father of Modern Pathology
“Virtually all forms of tissue injury
starts with molecular or structural
alterations in CELLS”
1821-1902
14 April 2019 4
The Scope of Pathology
Scientific knowledge about human diseases from observations on
patients or by from experimental studies.
Explain the whys and wherefores of signs and symptoms expressed.
It offers clinical care and therapy.
It serves as the bridge between basic sciences and clinical medicine.
Pathology is the foundation for all medicine.
14 April 2019 5
Core aspects of pathology
There are four aspects of diseases process that form the core of
pathology. These are following-
1. Etiology
2. Pathogenesis
3. Molecular and morphological changes
4. Clinical manifestations
14 April 2019 6
Etiology
Pathogenesis
Morphological
changes
Clinical
manifestations
1. Genetics
 Inherited mutation
 Diseases gene
mutation
2. Non-genetics
 Infectious
 Nutritional
 Physical
 chemical
14 April 2019 7
Etiology
Pathogenesis
Morphological
changes
Clinical
manifestations
 Mechanism of its
developments.
 Sequences of events in the
response of cells or tissues
to the etiologic agents.
 from the initial stimulus to
the ultimate expression of
the diseases.
14 April 2019 8
Etiology
Pathogenesis
Morphological
changes
Clinical
manifestations
 Molecular and Morphologic
changes refer to the
structural alterations in
cells or tissues that are
either characteristic of a
disease or diagnostic of an
etiologic process.
14 April 2019 9
Etiology
Pathogenesis
Morphological
changes
Clinical
manifestations
 The end results of genetic,
biochemical and structural
changes in cells and tissues
are functional
abnormalities, which lead
to the clinical
manifestations (symptoms
and signs) of disease, as
well as its progress.14 April 2019 10
Stages of the Cellular Responses
Fig: Stages of the cellular response to stress and injurious stimuli
14 April 2019 11
Adaptation
 Adaptations are reversible changes in the size, number, phenotype,
metabolic activity or functions of cells in response to changes in their
environment.
 Four types of adaptation are occurred-
• Hypertrophy
• Hyperplasia
• Atrophy
• Metaplasia
14 April 2019 12
Hypertrophy
• Hypertrophy is an increase in the size of cells resulting in an increase
in the size of the organ.
• There are no new cells, just large cells.
• Hypertrophy can be physiologic or
pathologic.
14 April 2019 13
Example
Pathologic hypertrophy
Cardiac enlargement that
occurs with hypertension
or aortic valve disease.
Physiologic hypertrophy
 Bulging muscles of bodybuilders.
14 April 2019 14
Physiologic hypertrophy
Enlargement of the uterus during pregnancy
14 April 2019 15
Mechanisms of Hypertrophy
Hypertrophy is the result of increased production of cellular proteins.
14 April 2019 16
Hyperplasia
• Hyperplasia is an increase in the number of cells in an organ or
tissue, resulting in increased mass of the organ or tissue.
• Hyperplasia can be physiologic or pathologic.
• In both situations, cellular proliferation is stimulated by growth
factors that are produced by a variety of cell types.
14 April 2019 17
Types
Physiologic hyperplasia
1. Hormonal hyperplasia:
The proliferation of the glandular epithelium of
the female breast at puberty and during
pregnancy.
2. Compensatory hyperplasia:
When part of a liver is resected, mitotic activity in
the remaining cells begins as early as 12 hours
later, eventually restoring the liver to its normal
size.
14 April 2019 18
Pathologic Hyperplasia
 Most forms of pathologic hyperplasia are caused by excesses of
hormones or growth factors acting on target cells.
 Example:
Endometrial hyperplasia is an example of abnormal hormone
induced hyperplasia.
14 April 2019 19
Mechanisms of Hyperplasia
Hyperplasia is the result of growth factor, driven proliferation of
mature cells.
In some cases, by increased output of new cells from tissue stem
cells.
14 April 2019 20
Atrophy
• Atrophy is reduced size of an organ or tissue resulting from a
decrease in cell size and number.
• Atrophy represents a reduction in the structural components of the
cell.
14 April 2019 21
Common Causes of Atrophy
Decreased workload
Loss of innervation
Diminished blood supply
Inadequate nutrition
Loss of endocrine stimulation
Pressure
14 April 2019 22
Mechanisms of Atrophy
Atrophy results from decreased
protein synthesis and increased
protein degradation in cells.
Reduction metabolic activity.
Nutrient deficiency activates
ubiquitin ligases.
Autophagy
14 April 2019 23
Metaplasia
• Metaplasia is a reversible change in which one differentiated cell type
is replaced by another cell type.
• The most common epithelial metaplasia is columnar to squamous, as
occurs in the respiratory tract in response to chronic irritation.
14 April 2019 24
Mechanisms of Metaplasia
• Reprogramming of stem cells that are known to exist in normal
tissues.
• The precursor cell differentiated along a new pathway, signaled by
cytokines, growth factor and components of the cell in this
environment.
14 April 2019 25
Cell injury
• If the adaptive capability is
exceeded or if the external
stress is inherently harmful or
excessive, cell injury develops.
14 April 2019 26
Causes of Cell Injury
• Oxygen Deprivation
• Physical Agents
• Chemical Agents and Drugs
• Infectious Agents
• Immunologic Reactions
• Genetic Derangements
• Nutritional Imbalances
14 April 2019 27
Biochemical mechanisms of cell injury
14 April 2019 28
Pathologic Effects of Free Radicals
14 April 2019 29
Apoptosis
• Apoptosis is a pathway of cell death that is induced by a tightly
regulated suicide program in which cells destined to die activate
enzymes that degrade the cells own nuclear DNA and nuclear and
cytoplasmic proteins.
14 April 2019 30
CAUSES OF APOPTOSIS
Apoptosis in Physiologic Situations
Apoptosis serves to eliminate cells that are no longer needed and to
maintain a steady. It is important in the following physiologic situations:
The programmed destruction of cells during embryogenesis
Involution of hormone-dependent tissues upon hormone
withdrawal
Cell loss in proliferating cell populations
Elimination of potentially harmful self-reactive lymphocytes
Death of host cells that have served their useful purpose
14 April 2019 31
Apoptosis in Pathologic Conditions
Apoptosis eliminates cells that are injured beyond repair without
eliciting a host reaction, thus limiting collateral tissue damage.
DNA damage
Accumulation of mis-folded proteins
Cell death in certain infections
14 April 2019 32
MORPHOLOGIC AND BIOCHEMICAL
CHANGES IN APOPTOSIS
• Cell shrinkage
• Chromatin condensation
• Formation of cytoplasmic blebs and
apoptotic bodies
• Phagocytosis of apoptotic cells by
macrophages.
14 April 2019 33
Necrosis
• Necrosis is a form of
cell death in which
cellular membranes
fall apart and cellular
enzymes leak out and
ultimately digest the
cell.
14 April 2019 34
Necrosis and Apoptosis
14 April 2019 35
Intracellular Accumulations
• Under some circumstances, cells may accumulate abnormal amounts
of various substances, which may be harmless or may cause varying
degrees of injury.
• The substances fall into two categories:
Normal cellular constituents
ex: Water, lipids, proteins etc.
Abnormal substances
ex: Products of infectious agents, abnormal
synthesis/metabolism.
14 April 2019 36
Mechanisms of intracellular
accumulation
1. Abnormal metabolism
2. Mutations causing
alterations in protein
folding and transport
3. A deficiency of critical
enzymes
4. Inability to degrade
phagocytosed particles
14 April 2019 37
Various components of intracellular
accumulation
A. Depositions of lipids
a. Fatty change
b. Cholesterol deposition
B. Deposition of proteins
C. Deposition of glycogens
D. Deposition of pigments
E. Pathologic calcifications
a. Dystrophic calcification
b. Metastatic calcification
14 April 2019 38
THANK YOU
14 April 2019 39
14 April 2019 40

More Related Content

What's hot

Cell injury & Cell death
Cell injury & Cell deathCell injury & Cell death
Cell injury & Cell deathSuraj Dhara
 
Cell injury, adaptation, and death fix
Cell injury, adaptation, and death fix Cell injury, adaptation, and death fix
Cell injury, adaptation, and death fix Raniagaye Mansibang
 
Ch 2 adaptations, cell injury, cell death
Ch 2 adaptations, cell injury, cell deathCh 2 adaptations, cell injury, cell death
Ch 2 adaptations, cell injury, cell deathAshish Jawarkar
 
Introduction of pathology
Introduction of pathologyIntroduction of pathology
Introduction of pathologyNailaawal
 
Cell injury adaptation class 1
Cell injury adaptation class 1Cell injury adaptation class 1
Cell injury adaptation class 1iqra khan
 
Principles of cell injury and cellular adaptation .ppt
Principles of cell injury and cellular adaptation .pptPrinciples of cell injury and cellular adaptation .ppt
Principles of cell injury and cellular adaptation .pptMirza Anwar Baig
 
Cell Injury, Adaptation And Accumulations
Cell Injury, Adaptation And AccumulationsCell Injury, Adaptation And Accumulations
Cell Injury, Adaptation And AccumulationsMD Specialclass
 
Introduction to pathology
Introduction to pathologyIntroduction to pathology
Introduction to pathologyJomin George
 
General pathology lecture 1 introduction & cell injury
General pathology lecture 1 introduction & cell injuryGeneral pathology lecture 1 introduction & cell injury
General pathology lecture 1 introduction & cell injuryHuang Yu-Wen
 
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia HusainPathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia HusainSufia Husain
 
Cell adaptation and injury
Cell adaptation and injuryCell adaptation and injury
Cell adaptation and injuryAmi Febriza
 
Cell injury: causes, pathogenesis, Morphology of reversible cell injury
Cell injury: causes, pathogenesis, Morphology of reversible cell injuryCell injury: causes, pathogenesis, Morphology of reversible cell injury
Cell injury: causes, pathogenesis, Morphology of reversible cell injuryVijay Shankar
 
Necrosis and apoptosis
Necrosis and apoptosisNecrosis and apoptosis
Necrosis and apoptosisAymen Kareem
 
Cell Injury And Death Lecture I
Cell Injury And Death    Lecture ICell Injury And Death    Lecture I
Cell Injury And Death Lecture Ibilalrana
 

What's hot (20)

Cell injury & Cell death
Cell injury & Cell deathCell injury & Cell death
Cell injury & Cell death
 
Cell injury, adaptation, and death fix
Cell injury, adaptation, and death fix Cell injury, adaptation, and death fix
Cell injury, adaptation, and death fix
 
Ch 2 adaptations, cell injury, cell death
Ch 2 adaptations, cell injury, cell deathCh 2 adaptations, cell injury, cell death
Ch 2 adaptations, cell injury, cell death
 
Introduction of pathology
Introduction of pathologyIntroduction of pathology
Introduction of pathology
 
Hemodynamic disorders
Hemodynamic disorders Hemodynamic disorders
Hemodynamic disorders
 
Cell injury adaptation class 1
Cell injury adaptation class 1Cell injury adaptation class 1
Cell injury adaptation class 1
 
Principles of cell injury and cellular adaptation .ppt
Principles of cell injury and cellular adaptation .pptPrinciples of cell injury and cellular adaptation .ppt
Principles of cell injury and cellular adaptation .ppt
 
Cell Injury, Adaptation And Accumulations
Cell Injury, Adaptation And AccumulationsCell Injury, Adaptation And Accumulations
Cell Injury, Adaptation And Accumulations
 
Introduction to pathology
Introduction to pathologyIntroduction to pathology
Introduction to pathology
 
Cell injury 2
Cell injury 2Cell injury 2
Cell injury 2
 
General pathology lecture 1 introduction & cell injury
General pathology lecture 1 introduction & cell injuryGeneral pathology lecture 1 introduction & cell injury
General pathology lecture 1 introduction & cell injury
 
Reversible Cell Injury
Reversible Cell InjuryReversible Cell Injury
Reversible Cell Injury
 
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia HusainPathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
 
Cell adaptation and injury
Cell adaptation and injuryCell adaptation and injury
Cell adaptation and injury
 
Cell injury: causes, pathogenesis, Morphology of reversible cell injury
Cell injury: causes, pathogenesis, Morphology of reversible cell injuryCell injury: causes, pathogenesis, Morphology of reversible cell injury
Cell injury: causes, pathogenesis, Morphology of reversible cell injury
 
Hemodynamic Disorders
Hemodynamic DisordersHemodynamic Disorders
Hemodynamic Disorders
 
Introduction to pathology
Introduction to pathologyIntroduction to pathology
Introduction to pathology
 
Necrosis and apoptosis
Necrosis and apoptosisNecrosis and apoptosis
Necrosis and apoptosis
 
Cell injury
Cell injuryCell injury
Cell injury
 
Cell Injury And Death Lecture I
Cell Injury And Death    Lecture ICell Injury And Death    Lecture I
Cell Injury And Death Lecture I
 

Similar to Cellular injury and adaptation

Basic Pathology : Introduction To Cells & Tissue Damage
Basic Pathology : Introduction To Cells & Tissue DamageBasic Pathology : Introduction To Cells & Tissue Damage
Basic Pathology : Introduction To Cells & Tissue DamageSado Anatomist
 
Basic pathophysiology.pptx
Basic pathophysiology.pptxBasic pathophysiology.pptx
Basic pathophysiology.pptxDrirFaisalHasan
 
Pathology presentation by Dr Jabessa.pptx
Pathology presentation by Dr Jabessa.pptxPathology presentation by Dr Jabessa.pptx
Pathology presentation by Dr Jabessa.pptxRebiraWorkineh
 
Introduction to pathology.pptx
Introduction to pathology.pptxIntroduction to pathology.pptx
Introduction to pathology.pptxYomif3
 
Basic principles of cell injury and adaptation
Basic principles of cell injury and adaptationBasic principles of cell injury and adaptation
Basic principles of cell injury and adaptationshivangimistry3
 
Cell injury, cell death & adaptations by Dr Nadeem (RMC)
Cell injury, cell death & adaptations by Dr Nadeem (RMC)Cell injury, cell death & adaptations by Dr Nadeem (RMC)
Cell injury, cell death & adaptations by Dr Nadeem (RMC)Hassan Ahmad
 
PN 1080 Unit 1 Intro to Pathophysiology.pptx
PN 1080 Unit 1 Intro to Pathophysiology.pptxPN 1080 Unit 1 Intro to Pathophysiology.pptx
PN 1080 Unit 1 Intro to Pathophysiology.pptxRachelBurwell1
 
1 Class Cellular Adaptation.pptx
1 Class Cellular Adaptation.pptx1 Class Cellular Adaptation.pptx
1 Class Cellular Adaptation.pptxReetuBaral
 
Cell injury and Cellular Adaptation: Pathology
Cell injury and Cellular Adaptation: PathologyCell injury and Cellular Adaptation: Pathology
Cell injury and Cellular Adaptation: PathologyHarshit Jadav
 
1. introduction
1. introduction1. introduction
1. introductionkciapm
 
cell injury and adaptation
cell injury and adaptationcell injury and adaptation
cell injury and adaptationDrvidhyaSivadas
 
PATHOLOGY -Dr- Ammar Omar -Assistant professor of Histopathology -Departmen...
PATHOLOGY -Dr- Ammar Omar -Assistant professor of Histopathology   -Departmen...PATHOLOGY -Dr- Ammar Omar -Assistant professor of Histopathology   -Departmen...
PATHOLOGY -Dr- Ammar Omar -Assistant professor of Histopathology -Departmen...ArfatAlmuallad
 
Cellular adaptation
Cellular adaptationCellular adaptation
Cellular adaptationLaraibTariq5
 

Similar to Cellular injury and adaptation (20)

basic pathology.pdf
basic pathology.pdfbasic pathology.pdf
basic pathology.pdf
 
Basic Pathology : Introduction To Cells & Tissue Damage
Basic Pathology : Introduction To Cells & Tissue DamageBasic Pathology : Introduction To Cells & Tissue Damage
Basic Pathology : Introduction To Cells & Tissue Damage
 
Cell injury
Cell injuryCell injury
Cell injury
 
Lab 10
Lab  10Lab  10
Lab 10
 
Mod+11 2017
Mod+11 2017Mod+11 2017
Mod+11 2017
 
Basic pathophysiology.pptx
Basic pathophysiology.pptxBasic pathophysiology.pptx
Basic pathophysiology.pptx
 
Basic pathophysiology.pptx
Basic pathophysiology.pptxBasic pathophysiology.pptx
Basic pathophysiology.pptx
 
Pathology presentation by Dr Jabessa.pptx
Pathology presentation by Dr Jabessa.pptxPathology presentation by Dr Jabessa.pptx
Pathology presentation by Dr Jabessa.pptx
 
Introduction to pathology.pptx
Introduction to pathology.pptxIntroduction to pathology.pptx
Introduction to pathology.pptx
 
Basic principles of cell injury and adaptation
Basic principles of cell injury and adaptationBasic principles of cell injury and adaptation
Basic principles of cell injury and adaptation
 
Cell injury, cell death & adaptations by Dr Nadeem (RMC)
Cell injury, cell death & adaptations by Dr Nadeem (RMC)Cell injury, cell death & adaptations by Dr Nadeem (RMC)
Cell injury, cell death & adaptations by Dr Nadeem (RMC)
 
001.genetics
001.genetics001.genetics
001.genetics
 
PN 1080 Unit 1 Intro to Pathophysiology.pptx
PN 1080 Unit 1 Intro to Pathophysiology.pptxPN 1080 Unit 1 Intro to Pathophysiology.pptx
PN 1080 Unit 1 Intro to Pathophysiology.pptx
 
1 Class Cellular Adaptation.pptx
1 Class Cellular Adaptation.pptx1 Class Cellular Adaptation.pptx
1 Class Cellular Adaptation.pptx
 
Cell injury and Cellular Adaptation: Pathology
Cell injury and Cellular Adaptation: PathologyCell injury and Cellular Adaptation: Pathology
Cell injury and Cellular Adaptation: Pathology
 
1. introduction
1. introduction1. introduction
1. introduction
 
cell injury and adaptation
cell injury and adaptationcell injury and adaptation
cell injury and adaptation
 
PATHOLOGY -Dr- Ammar Omar -Assistant professor of Histopathology -Departmen...
PATHOLOGY -Dr- Ammar Omar -Assistant professor of Histopathology   -Departmen...PATHOLOGY -Dr- Ammar Omar -Assistant professor of Histopathology   -Departmen...
PATHOLOGY -Dr- Ammar Omar -Assistant professor of Histopathology -Departmen...
 
Cell injury
Cell injuryCell injury
Cell injury
 
Cellular adaptation
Cellular adaptationCellular adaptation
Cellular adaptation
 

More from Rana Ahmed

Roles of nutraceuticals
Roles of nutraceuticalsRoles of nutraceuticals
Roles of nutraceuticalsRana Ahmed
 
The Drug (control) Ordinance, 1982
The Drug (control) Ordinance, 1982The Drug (control) Ordinance, 1982
The Drug (control) Ordinance, 1982Rana Ahmed
 
The manufacture of cosmetics
The manufacture of cosmeticsThe manufacture of cosmetics
The manufacture of cosmeticsRana Ahmed
 
Enzyme in-therapy-1-1
Enzyme in-therapy-1-1Enzyme in-therapy-1-1
Enzyme in-therapy-1-1Rana Ahmed
 
One compartment-open-model
One compartment-open-modelOne compartment-open-model
One compartment-open-modelRana Ahmed
 
Printed promotion material of Ebastine
Printed promotion material of EbastinePrinted promotion material of Ebastine
Printed promotion material of EbastineRana Ahmed
 
Lung cancer(1)
Lung cancer(1)Lung cancer(1)
Lung cancer(1)Rana Ahmed
 
Advanced tablet and capsule packaging
Advanced tablet and capsule packagingAdvanced tablet and capsule packaging
Advanced tablet and capsule packagingRana Ahmed
 
Nutritional diseases of Poultry
Nutritional diseases of PoultryNutritional diseases of Poultry
Nutritional diseases of PoultryRana Ahmed
 

More from Rana Ahmed (9)

Roles of nutraceuticals
Roles of nutraceuticalsRoles of nutraceuticals
Roles of nutraceuticals
 
The Drug (control) Ordinance, 1982
The Drug (control) Ordinance, 1982The Drug (control) Ordinance, 1982
The Drug (control) Ordinance, 1982
 
The manufacture of cosmetics
The manufacture of cosmeticsThe manufacture of cosmetics
The manufacture of cosmetics
 
Enzyme in-therapy-1-1
Enzyme in-therapy-1-1Enzyme in-therapy-1-1
Enzyme in-therapy-1-1
 
One compartment-open-model
One compartment-open-modelOne compartment-open-model
One compartment-open-model
 
Printed promotion material of Ebastine
Printed promotion material of EbastinePrinted promotion material of Ebastine
Printed promotion material of Ebastine
 
Lung cancer(1)
Lung cancer(1)Lung cancer(1)
Lung cancer(1)
 
Advanced tablet and capsule packaging
Advanced tablet and capsule packagingAdvanced tablet and capsule packaging
Advanced tablet and capsule packaging
 
Nutritional diseases of Poultry
Nutritional diseases of PoultryNutritional diseases of Poultry
Nutritional diseases of Poultry
 

Recently uploaded

CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 

Recently uploaded (20)

CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 

Cellular injury and adaptation

  • 1. Antecedents Group no. 01 Group Members: Rana Ahmed (PHA-14001) Mahfujul Hasan (PHA-14002) Shahida Yeasmin Sima (PHA-14005) Shamima Akter Sumi (PHA-14007) 14 April 2019 1
  • 2. Contents Introduction to Pathology Definition Father of Modern Pathology Scope Core aspects Cellular Injury and Adaptation Stages of the cellular response Adaptation Hypertrophy Hyperplasia Atrophy Metaplasia Cell injury Intracellular Accumulations 14 April 2019 2
  • 3. What Is Pathology • Pathology is the study (logos) of diseases (pathos). • The study of the structural, biochemical and functional changes in cells, tissues and organs that underlie diseases. • It attempts to explain sign and symptoms by use of Molecular Microbiologic Immunologic Morphologic techniques 14 April 2019 3
  • 4. Rudolf Virchow Father of Modern Pathology “Virtually all forms of tissue injury starts with molecular or structural alterations in CELLS” 1821-1902 14 April 2019 4
  • 5. The Scope of Pathology Scientific knowledge about human diseases from observations on patients or by from experimental studies. Explain the whys and wherefores of signs and symptoms expressed. It offers clinical care and therapy. It serves as the bridge between basic sciences and clinical medicine. Pathology is the foundation for all medicine. 14 April 2019 5
  • 6. Core aspects of pathology There are four aspects of diseases process that form the core of pathology. These are following- 1. Etiology 2. Pathogenesis 3. Molecular and morphological changes 4. Clinical manifestations 14 April 2019 6
  • 7. Etiology Pathogenesis Morphological changes Clinical manifestations 1. Genetics  Inherited mutation  Diseases gene mutation 2. Non-genetics  Infectious  Nutritional  Physical  chemical 14 April 2019 7
  • 8. Etiology Pathogenesis Morphological changes Clinical manifestations  Mechanism of its developments.  Sequences of events in the response of cells or tissues to the etiologic agents.  from the initial stimulus to the ultimate expression of the diseases. 14 April 2019 8
  • 9. Etiology Pathogenesis Morphological changes Clinical manifestations  Molecular and Morphologic changes refer to the structural alterations in cells or tissues that are either characteristic of a disease or diagnostic of an etiologic process. 14 April 2019 9
  • 10. Etiology Pathogenesis Morphological changes Clinical manifestations  The end results of genetic, biochemical and structural changes in cells and tissues are functional abnormalities, which lead to the clinical manifestations (symptoms and signs) of disease, as well as its progress.14 April 2019 10
  • 11. Stages of the Cellular Responses Fig: Stages of the cellular response to stress and injurious stimuli 14 April 2019 11
  • 12. Adaptation  Adaptations are reversible changes in the size, number, phenotype, metabolic activity or functions of cells in response to changes in their environment.  Four types of adaptation are occurred- • Hypertrophy • Hyperplasia • Atrophy • Metaplasia 14 April 2019 12
  • 13. Hypertrophy • Hypertrophy is an increase in the size of cells resulting in an increase in the size of the organ. • There are no new cells, just large cells. • Hypertrophy can be physiologic or pathologic. 14 April 2019 13
  • 14. Example Pathologic hypertrophy Cardiac enlargement that occurs with hypertension or aortic valve disease. Physiologic hypertrophy  Bulging muscles of bodybuilders. 14 April 2019 14
  • 15. Physiologic hypertrophy Enlargement of the uterus during pregnancy 14 April 2019 15
  • 16. Mechanisms of Hypertrophy Hypertrophy is the result of increased production of cellular proteins. 14 April 2019 16
  • 17. Hyperplasia • Hyperplasia is an increase in the number of cells in an organ or tissue, resulting in increased mass of the organ or tissue. • Hyperplasia can be physiologic or pathologic. • In both situations, cellular proliferation is stimulated by growth factors that are produced by a variety of cell types. 14 April 2019 17
  • 18. Types Physiologic hyperplasia 1. Hormonal hyperplasia: The proliferation of the glandular epithelium of the female breast at puberty and during pregnancy. 2. Compensatory hyperplasia: When part of a liver is resected, mitotic activity in the remaining cells begins as early as 12 hours later, eventually restoring the liver to its normal size. 14 April 2019 18
  • 19. Pathologic Hyperplasia  Most forms of pathologic hyperplasia are caused by excesses of hormones or growth factors acting on target cells.  Example: Endometrial hyperplasia is an example of abnormal hormone induced hyperplasia. 14 April 2019 19
  • 20. Mechanisms of Hyperplasia Hyperplasia is the result of growth factor, driven proliferation of mature cells. In some cases, by increased output of new cells from tissue stem cells. 14 April 2019 20
  • 21. Atrophy • Atrophy is reduced size of an organ or tissue resulting from a decrease in cell size and number. • Atrophy represents a reduction in the structural components of the cell. 14 April 2019 21
  • 22. Common Causes of Atrophy Decreased workload Loss of innervation Diminished blood supply Inadequate nutrition Loss of endocrine stimulation Pressure 14 April 2019 22
  • 23. Mechanisms of Atrophy Atrophy results from decreased protein synthesis and increased protein degradation in cells. Reduction metabolic activity. Nutrient deficiency activates ubiquitin ligases. Autophagy 14 April 2019 23
  • 24. Metaplasia • Metaplasia is a reversible change in which one differentiated cell type is replaced by another cell type. • The most common epithelial metaplasia is columnar to squamous, as occurs in the respiratory tract in response to chronic irritation. 14 April 2019 24
  • 25. Mechanisms of Metaplasia • Reprogramming of stem cells that are known to exist in normal tissues. • The precursor cell differentiated along a new pathway, signaled by cytokines, growth factor and components of the cell in this environment. 14 April 2019 25
  • 26. Cell injury • If the adaptive capability is exceeded or if the external stress is inherently harmful or excessive, cell injury develops. 14 April 2019 26
  • 27. Causes of Cell Injury • Oxygen Deprivation • Physical Agents • Chemical Agents and Drugs • Infectious Agents • Immunologic Reactions • Genetic Derangements • Nutritional Imbalances 14 April 2019 27
  • 28. Biochemical mechanisms of cell injury 14 April 2019 28
  • 29. Pathologic Effects of Free Radicals 14 April 2019 29
  • 30. Apoptosis • Apoptosis is a pathway of cell death that is induced by a tightly regulated suicide program in which cells destined to die activate enzymes that degrade the cells own nuclear DNA and nuclear and cytoplasmic proteins. 14 April 2019 30
  • 31. CAUSES OF APOPTOSIS Apoptosis in Physiologic Situations Apoptosis serves to eliminate cells that are no longer needed and to maintain a steady. It is important in the following physiologic situations: The programmed destruction of cells during embryogenesis Involution of hormone-dependent tissues upon hormone withdrawal Cell loss in proliferating cell populations Elimination of potentially harmful self-reactive lymphocytes Death of host cells that have served their useful purpose 14 April 2019 31
  • 32. Apoptosis in Pathologic Conditions Apoptosis eliminates cells that are injured beyond repair without eliciting a host reaction, thus limiting collateral tissue damage. DNA damage Accumulation of mis-folded proteins Cell death in certain infections 14 April 2019 32
  • 33. MORPHOLOGIC AND BIOCHEMICAL CHANGES IN APOPTOSIS • Cell shrinkage • Chromatin condensation • Formation of cytoplasmic blebs and apoptotic bodies • Phagocytosis of apoptotic cells by macrophages. 14 April 2019 33
  • 34. Necrosis • Necrosis is a form of cell death in which cellular membranes fall apart and cellular enzymes leak out and ultimately digest the cell. 14 April 2019 34
  • 35. Necrosis and Apoptosis 14 April 2019 35
  • 36. Intracellular Accumulations • Under some circumstances, cells may accumulate abnormal amounts of various substances, which may be harmless or may cause varying degrees of injury. • The substances fall into two categories: Normal cellular constituents ex: Water, lipids, proteins etc. Abnormal substances ex: Products of infectious agents, abnormal synthesis/metabolism. 14 April 2019 36
  • 37. Mechanisms of intracellular accumulation 1. Abnormal metabolism 2. Mutations causing alterations in protein folding and transport 3. A deficiency of critical enzymes 4. Inability to degrade phagocytosed particles 14 April 2019 37
  • 38. Various components of intracellular accumulation A. Depositions of lipids a. Fatty change b. Cholesterol deposition B. Deposition of proteins C. Deposition of glycogens D. Deposition of pigments E. Pathologic calcifications a. Dystrophic calcification b. Metastatic calcification 14 April 2019 38